- Home
- Media Center
- Press releases
- Financial
Financial
Johnson & Johnson Reports Q4 and Full-Year 2021 Results
2021 Fourth-Quarter Sales of $24.8 Billion reflecting growth of 10.4%, operational sales growth of 11.6%*, and adjusted operational sales growth of 12.3%* 2021 Full-Year Sales of $93.8 Billion reflecting growth of 13.6%, operational sales growth of 12.2%*, and adjusted operational sales growth of 12.8%* 2021 Fourth-Quarter EPS of $1.77 increased 172.3%; adjusted EPS of $2.13 increased 14.5%* 2021 Full-Year EPS of $7.81 increased 41.7%; adjusted EPS of $9.80 increased 22.0%* Company guides 2022 adjusted operational sales growth of 7.7%* and adjusted operational EPS growth of 9.2%*
Johnson & Johnson Reports Q3 2021 Results
Total sales growth of 10.7% to $23.3 Billion with operational growth of 9.9%* and adjusted operational growth of 10.6%* Earnings per share of $1.37 increasing 3.0% and adjusted earnings per share of $2.60 increasing 18.2%* Company increasing 2021 Full-Year Guidance